> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Advisory Panel to Address Breast Implant Benefit/Risk
- URL: https://www.fdaweb.com/advisory-panel-to-address-breast-implant-benefit-risk/
- Published: 2019-01-28T12:00:00.000Z
- Updated: 2026-09-15T00:57:42.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5143239

FDA has [announced](https://t.co/uTOUzi1Rmv?ref=fdaweb.com) a 3/25-26 General and Plastic Surgery Devices Panel meeting to discuss topics concerning the benefit-risk profile of breast implants. The agency plans to publish a *Federal Register* notice and agenda on its [Advisory Committee Calendar Web page](https://www.fda.gov/AdvisoryCommittees/Calendar/ucm2005376.htm?ref=fdaweb.com) 15 days in advance of the meeting. In commenting about the meeting, FDA commissioner **Scott Gottlieb** says the agency will seek public input on “benefit/risk considerations and possible measures to further address certain risks with breast implants to help ensure the public continues to have accurate, scientifically-sound information about the benefits and risks of breast implants.”